Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group.
Dimopoulos MA, Fountzilas G, Papageorgiou E, Kiamouris C, Mantzios G, Anagnostopoulos A, Nicolaides C, Economopoulos T; Hellenic Cooperative Oncology Group. Dimopoulos MA, et al. Among authors: economopoulos t. Leuk Lymphoma. 2002 Jan;43(1):111-4. doi: 10.1080/10428190210177. Leuk Lymphoma. 2002. PMID: 11908713 Clinical Trial.
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.
Papageorgiou ES, Tsirigotis P, Dimopoulos M, Pavlidis N, Fountzilas G, Papageorgiou S, Economopoulos T; Hellenic Cooperative Oncology Group. Papageorgiou ES, et al. Among authors: economopoulos t. Eur J Haematol. 2005 Aug;75(2):124-9. doi: 10.1111/j.1600-0609.2005.00482.x. Eur J Haematol. 2005. PMID: 16000128 Clinical Trial.
Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas.
Economopoulos T, Papageorgiou S, Pappa V, Papageorgiou E, Valsami S, Kalantzis D, Xiros N, Dervenoulas J, Raptis S. Economopoulos T, et al. Leuk Res. 2003 Jun;27(6):505-8. doi: 10.1016/s0145-2126(02)00277-1. Leuk Res. 2003. PMID: 12648510
Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study.
Pectasides D, Pectasides M, Farmakis D, Aravantinos G, Nikolaou M, Koumpou M, Gaglia A, Kostopoulou V, Mylonakis N, Economopoulos T, Raptis SA. Pectasides D, et al. Among authors: economopoulos t. Eur Urol. 2004 Aug;46(2):216-21. doi: 10.1016/j.eururo.2004.03.001. Eur Urol. 2004. PMID: 15245816 Clinical Trial.
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Skarlos DV, Kalofonos HP, Fountzilas G, Dimopoulos MA, Pavlidis N, Razis E, Economopoulos T, Pectasides D, Gogas H, Kosmidis P, Bafaloukos D, Klouvas G, Kyratzis G, Aravantinos G. Skarlos DV, et al. Among authors: economopoulos t. Anticancer Res. 2005 Jul-Aug;25(4):3103-8. Anticancer Res. 2005. PMID: 16080573 Free article. Clinical Trial.
228 results